ME Therapeutics Holdings Inc., a publicly listed biotechnology company focused on developing innovative cancer therapies in the field of immuno-oncology, today announced a significant milestone in its in vivo CAR cell therapy program. The Company’s subsidiary, ME Therapeutics Inc., has…
Y.ora Vision, Inc., a newly established ophthalmic medical device company and a spoke company of Eyexora, has officially announced the signing of a licensing agreement between the Singapore Eye Research Institute (SERI) and Eyexora Global. The agreement is set to…
Scanogen Inc., a molecular diagnostics company at the forefront of next-generation infectious disease detection, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its rapid assay designed to identify bloodstream infection pathogens directly from…
WaHa Inc. proudly celebrates its co-founder, Professor Omar M. Yaghi, recipient of the 2025 Nobel Prize in Chemistry, awarded by the Royal Swedish Academy of Sciences. The global scientific community recognizes Professor Yaghi’s groundbreaking contributions to reticular chemistry—a field he…
Libra Therapeutics, Inc., a private biotechnology company pioneering novel disease-modifying therapeutics designed to restore cellular homeostasis and slow the progression of neurodegenerative diseases, today announced the promotion of Martin (Marty) Gill, Ph.D., to Chief Scientific Officer (CSO). Dr. Gill, who…
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the establishment of a global, cross-functional Scientific Advisory Board to guide the company’s strategic focus on New Approach Methodologies (NAMs). The Advisory Board, led by Dr. Namandjé N. Bumpus, will play…
MindWalk Holdings Corp.™, a Bio-Native AI company transforming life sciences data intelligence, today announced the appointment of industry veteran Thomas W. Lynch, Ph.D., as Chief Business Officer (CBO), effective October 20, 2025. This strategic hire is aimed at accelerating the…
Orum Therapeutics, a public biotechnology company pioneering the development of degrader–antibody conjugates (DACs), has announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. With over 27 years of experience in drug discovery and more than 15 years…
Farmland LP, the largest U.S. manager exclusively focused on organic and regenerative farmland, together with Carbon Friendly, a leading developer of regenerative carbon projects, have achieved a major milestone in the voluntary carbon market. The two organizations have submitted the…
Deep Genomics, the AI-first TechBio company pioneering next-generation genomic medicines through its advanced AI foundation model platform, today announced the appointment of Thong Q. Le and Paul Sekhri to its Board of Directors. These appointments strengthen Deep Genomics’ leadership as…